Sullivan & Cromwell

Brad King

Deals
3
Latest
Jul 2026
Most deals in
Biotech

Firm

Deals by year
Brad King: deals by year0320252026 YTD: 2 M&A2026 YTD: 1 Equity raisings32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Brad King was named on, most recent first
Jul 2026 AtaiBeckley –Eli Lilly and CompanyAcquisitionLegal adviser to Apeiron Investment Group (target)Announced2,800.0Biotech+2Eli Lilly and Company acquisition of AtaiBeckley
Jul 2026 Avere Therapeutics ––PlacementLegal adviser to Hansoh PharmaAnnounced320.0Biotech+1Avere Therapeutics placement
Jul 2026 Avere Therapeutics –NextCureMergerLegal adviser to Hansoh PharmaAnnounced–Biotech+1NextCure and Avere Therapeutics merger

Deals where Brad King is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.